2023-12-17 21:30:41
Published on December 17, 2023 at 10:30 p.m.
Stocks or bonds? United States or Europe? The year 2024 should be marked by the normalization of Western monetary policies. What will the investment prospects be? Elements of response in the special file that The weather and its Alex Reed contributors devote to the theme.
Medicines for humans and pets, liquefied natural gas or recliners made in the USA: the experts we interviewed, like every year end, proposed a wide range of sectors of activity to provide investment ideas for 2024. Overview.
« Roche should wake up at some point,” says Jérôme Schupp, head of research at Prime Partners. Big pharma suffered enormously, like some of its competitors, following benefiting from sales of products linked to covid (diagnostics in the case of Roche) and the end of patents on certain flagship products such as Avastin or Mabthera. The group has invested heavily in new products. From the second quarter of 2024, sales growth is expected to accelerate. Roche shares are also cheap, while the dividend and cash flow remain high. A little patience may be necessary, explains Jérôme Schupp.
Interested in this item?
Don’t miss any of our content published daily – subscribe now to access all our articles, files, and analyzes
Until December 25, enjoy 30% off all our subscriptions
CHECK OFFERS Good reasons to subscribe to Le Temps:
-
Consult all unlimited content on the site and the mobile application
-
Access the paper edition in digital version before 7 a.m.
-
Benefit from exclusive privileges reserved for subscribers
-
Access the archives
Already a subscriber? To log in
1702854143
#Ten #actions #follow
